- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose
NAG.13: 3 residues within 4Å:- Chain D: N.106, T.108, N.109
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain D: N.147, N.148
Ligand excluded by PLIPNAG.15: 9 residues within 4Å:- Chain D: T.92, N.217, T.219
- Chain F: R.440, K.441, K.443, L.444, K.445, E.448
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain D: N.263, E.264, N.265
- Chain F: K.541
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain D: N.314, Q.563
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain D: H.322, N.326
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain D: N.599, T.601
- Chain E: I.817
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain D: N.640
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain D: N.692
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain D: A.689, E.1055, N.1057
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain D: N.1117
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain E: N.106, T.108, N.109
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain E: N.147, N.148
Ligand excluded by PLIPNAG.26: 7 residues within 4Å:- Chain D: R.440, K.441, S.442, K.445
- Chain E: T.92, N.217, T.219
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain D: K.541
- Chain E: E.264, N.265
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain E: N.314, Q.563
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain E: H.322, N.326
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain E: N.599
- Chain F: I.817
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain E: N.640
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain E: Y.690, S.691, N.692
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain E: A.689, E.1055, N.1057
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain E: N.1117
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain F: N.106, T.108, N.109
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain F: N.147, N.148
Ligand excluded by PLIPNAG.37: 8 residues within 4Å:- Chain E: R.440, K.441, S.442, K.443, K.445, E.448
- Chain F: T.92, N.217
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain E: K.541
- Chain F: E.264, N.265
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain F: N.314, Q.563
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain F: H.322, N.326, N.353
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain D: I.817
- Chain F: N.599
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain F: N.640
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain F: Y.690, S.691, N.692
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain F: E.1055, N.1057
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain F: N.1117
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ye, G. et al., Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants. Plos Pathog. (2024)
- Release Date
- 2024-08-28
- Peptides
- Nanosota-5: ABC
Spike glycoprotein: DEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
MB
NC
OD
AE
BF
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 12 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ye, G. et al., Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants. Plos Pathog. (2024)
- Release Date
- 2024-08-28
- Peptides
- Nanosota-5: ABC
Spike glycoprotein: DEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
MB
NC
OD
AE
BF
C